Related Articles
Combination therapy with low molecular weight heparin and Adriamycin results in decreased breast cancer cell metastasis in C3H mice
Low molecular weight heparin suppresses tissue factor-mediated cancer cell invasion and migration in vitro
Heparin regulates B6FS cell motility through a FAK/actin cytoskeleton axis
Anti-angiogenic mechanisms and efficacy of the low molecular weight heparin, tinzaparin: Anti-cancer efficacy
Non-anti-coagulant heparin inhibits metastasis but not primary tumor growth